Skip Nav Destination
            
    
            
 
    
    
        
            
                
                    
                        
                        
                            
                        
                    
                
                    
                    
                        
                    
                
                
                    
                        
                        
                            
                        
                    
            
        
    
    
    
        
        
        
    
        
 
    
        
    
    
        
            
        
        
    
        
    
    
    
 
    
                
                    
            
    
        
    
    
                    
        
        
        Ofatumumab in diffuse large B cell lymphoma?
        
        
            
        
    
        
    
            
                
            
    
    
    
        
        
     
    
                    
        
        
     
    
                     
    
                     
    
                     
    
                    
                    
        
        Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma
        
        
            
        
    
        
                
            
    
    
    
                    
        
        Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children’s Oncology Group
        
        
            
        
    
        
                
            
    
    
    
                    
        
        Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                     
    
                     
    
                    
                    
        
        Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                    
                    
                
            
    
    
    
        
        
     
    
                     
    
                    
                    
                
            
    
    
    
        
        
     
    
                    
        
        
     
    
 
    
            
    
        
    
         
 
    
    
        
    
            
    
        
    
    
    
        
    
    
    
            
    
                    
 
    
    
 
    
    
        
    
    
    
            
        
 
    
    
 
    
    
         
    
    
        
    
    
    
            
    
                    
 
    
    
 
    
    
 
    
    
    
    
        
    Issue Archive
July 25 2013
    
    
Table of Contents
INSIDE BLOOD
CLINICAL TRIALS & OBSERVATIONS
                    
        
        Ofatumumab in diffuse large B cell lymphoma?
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
    
            BLOOD WORK
PLENARY PAPER
BLOOD SPOTLIGHT
REVIEW ARTICLE
CLINICAL TRIALS AND OBSERVATIONS
        
        Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Matthew J. Matasar,Myron S. Czuczman,Maria Alma Rodriguez,Michael Fennessy,Thomas C. Shea,Gary Spitzer,Izidore S. Lossos,Mohamed A. Kharfan-Dabaja,Robin Joyce,Luis Fayad,Kristen Henkel,Qiming Liao,Klaus Edvardsen,Roxanne C. Jewell,Doug Fecteau,Rajendra P. Singh,Steen Lisby,Craig H. Moskowitz
            
        
    
            
        
        Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children’s Oncology Group
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Wanda L. Salzer,Barbara Asselin,Jeffrey G. Supko,Meenakshi Devidas,Nicole A. Kaiser,Paul Plourde,Naomi J. Winick,Gregory H. Reaman,Elizabeth Raetz,William L. Carroll,Stephen P. Hunger
            
        
    
            
        
        Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            David M. Ross,Susan Branford,John F. Seymour,Anthony P. Schwarer,Christopher Arthur,David T. Yeung,Phuong Dang,Jarrad M. Goyne,Cassandra Slader,Robin J. Filshie,Anthony K. Mills,Junia V. Melo,Deborah L. White,Andrew P. Grigg,Timothy P. Hughes
            
        
    
            HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
        
        Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation
        
        
            
        
                    
                        Brief Report
                    
        
            
    
        
            Kevin R. Krull,Nan Zhang,Aimee Santucci,Deo Kumar Srivastava,Matthew J. Krasin,Larry E. Kun,Ching-Hon Pui,Leslie L. Robison,Melissa M. Hudson,Gregory T. Armstrong
            
        
    
            MYELOID NEOPLASIA
Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome
            Sergey I. Nikolaev,Federico Santoni,Anne Vannier,Emilie Falconnet,Emanuela Giarin,Giuseppe Basso,Alexander Hoischen,Joris A. Veltman,Jurgen Groet,Dean Nizetic,Stylianos E. Antonarakis
            
        
    
            PLATELETS AND THROMBOPOIESIS
THROMBOSIS AND HEMOSTASIS
Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project
            Jill M. Johnsen,on behalf of the NHLBI Exome Sequencing Project,Paul L. Auer,on behalf of the NHLBI Exome Sequencing Project,Alanna C. Morrison,on behalf of the NHLBI Exome Sequencing Project,Shuo Jiao,on behalf of the NHLBI Exome Sequencing Project,Peng Wei,on behalf of the NHLBI Exome Sequencing Project,Jeffrey Haessler,on behalf of the NHLBI Exome Sequencing Project,Keolu Fox,on behalf of the NHLBI Exome Sequencing Project,Sean R. McGee,on behalf of the NHLBI Exome Sequencing Project,Joshua D. Smith,on behalf of the NHLBI Exome Sequencing Project,Christopher S. Carlson,on behalf of the NHLBI Exome Sequencing Project,Nicholas Smith,on behalf of the NHLBI Exome Sequencing Project,Eric Boerwinkle,on behalf of the NHLBI Exome Sequencing Project,Charles Kooperberg,on behalf of the NHLBI Exome Sequencing Project,Deborah A. Nickerson,on behalf of the NHLBI Exome Sequencing Project,Stephen S. Rich,on behalf of the NHLBI Exome Sequencing Project,David Green,on behalf of the NHLBI Exome Sequencing Project,Ulrike Peters,on behalf of the NHLBI Exome Sequencing Project,Mary Cushman,on behalf of the NHLBI Exome Sequencing Project,Alex P. Reiner,on behalf of the NHLBI Exome Sequencing Project
            
        
    
            VASCULAR BIOLOGY
- 
        
            Cover Image
        
        Cover Image![issue cover]()  The authors demonstrate that the E3 ubiquitin ligase ASB2α, through degradation of its substrate filamins, acts as a positive regulator of podosome rosette formation, extracellular matrix degradation, and subsequent migration of immature dendritic cells. The cover image shows bone marrow-derived dendritic cells that were stained with antibodies to filamin A (green), vinculin (red), and phalloidin (blue). See the article by Lamsoul et al on page 533. 
- PDF Icon Front MatterFront Matter
- PDF Icon Table of ContentsTable of Contents
- PDF Icon Back MatterBack Matter
- PDF Icon AdvertisingAdvertising
- PDF Icon Editorial BoardEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
 
                    